Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services is a global CDMO with sites in Belgium, India, the US, and Japan. We provide comprehensive one-stop services from process development to GMP manufacturing of pharmaceutical ingredients and intermediates for small, medium, and large molecules, as well as gene therapy. Our capabilities span pre-clinical to commercial stages, supported by proprietary platforms: AJIPHASE® (liquid-phase oligo/peptide), CORYNEX® (microbial protein/peptide expression), AJICAP® (site-specific conjugation for drug conjugates), and Fuel (AAV gene therapy).

www.ajibio-pharma.com